Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dorothee Gramatzki

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
Cancer|September 14, 2016
Reply to glioblastoma in the Canton of Zurich, Switzerland revisited: 2005 to 2009Dorothee Gramatzki, Michael Weller
Current Neurology and Neuroscience Reports|March 22, 2017
Management of Elderly Patients with GlioblastomaPatrick Roth, Dorothee Gramatzki, Michael Weller
Expert Opinion on Pharmacotherapy|April 8, 2016
Pharmacotherapies for the treatment of glioblastoma - current evidence and perspectivesKatharina Seystahl, Dorothee Gramatzki, Patrick Roth, et al.
ESMO Open|November 13, 2020
Sex-specific and gender-specific aspects in patient-reported outcomesCaroline Hertler, Annina Seiler, Dorothee Gramatzki, et al.
Molecular and Cellular Biochemistry|March 27, 2021
A tumor-promoting role for soluble TβRIII in glioblastomaIsabel Burghardt, Judith Johanna Schroeder, Tobias Weiss, et al.
Hematology/Oncology Clinics of North America|November 10, 2021
Leptomeningeal DiseaseYolanda Piña, Dorothee Gramatzki, Peter Forsyth, et al.
Oncology Letters|June 28, 2016
Interleukin-33 in human gliomas: Expression and prognostic significanceDorothee Gramatzki, Karl Frei, Gieri Cathomas, et al.
Journal of Neuro-Oncology|April 2, 2020
End-of-life care for glioma patients; the caregivers' perspectiveCaroline Hertler, Günter Eisele, Dorothee Gramatzki, et al.
Journal of Cancer Research and Clinical Oncology|August 27, 2021
Radiotherapy for glioblastoma patients with poor performance statusChristina Schröder, Dorothee Gramatzki, Erwin Vu, et al.
Plos One|May 14, 2013
Glioma cell death induced by irradiation or alkylating agent chemotherapy is independent of the intrinsic ceramide pathwayDorothee Gramatzki, Caroline Herrmann, Caroline Happold, et al.
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Cancer|September 14, 2016
Reply to glioblastoma in the Canton of Zurich, Switzerland revisited: 2005 to 2009Dorothee Gramatzki, Michael Weller
Current Neurology and Neuroscience Reports|March 22, 2017
Management of Elderly Patients with GlioblastomaPatrick Roth, Dorothee Gramatzki, Michael Weller
Expert Opinion on Pharmacotherapy|April 8, 2016
Pharmacotherapies for the treatment of glioblastoma - current evidence and perspectivesKatharina Seystahl, Dorothee Gramatzki, Patrick Roth, et al.
ESMO Open|November 13, 2020
Sex-specific and gender-specific aspects in patient-reported outcomesCaroline Hertler, Annina Seiler, Dorothee Gramatzki, et al.
Molecular and Cellular Biochemistry|March 27, 2021
A tumor-promoting role for soluble TβRIII in glioblastomaIsabel Burghardt, Judith Johanna Schroeder, Tobias Weiss, et al.
Hematology/Oncology Clinics of North America|November 10, 2021
Leptomeningeal DiseaseYolanda Piña, Dorothee Gramatzki, Peter Forsyth, et al.
Oncology Letters|June 28, 2016
Interleukin-33 in human gliomas: Expression and prognostic significanceDorothee Gramatzki, Karl Frei, Gieri Cathomas, et al.
Journal of Neuro-Oncology|April 2, 2020
End-of-life care for glioma patients; the caregivers' perspectiveCaroline Hertler, Günter Eisele, Dorothee Gramatzki, et al.
Journal of Cancer Research and Clinical Oncology|August 27, 2021
Radiotherapy for glioblastoma patients with poor performance statusChristina Schröder, Dorothee Gramatzki, Erwin Vu, et al.
Plos One|May 14, 2013
Glioma cell death induced by irradiation or alkylating agent chemotherapy is independent of the intrinsic ceramide pathwayDorothee Gramatzki, Caroline Herrmann, Caroline Happold, et al.
Pageof 6